AU604249B2 - Macrocyclic compounds - Google Patents
Macrocyclic compoundsInfo
- Publication number
- AU604249B2 AU604249B2 AU76217/87A AU7621787A AU604249B2 AU 604249 B2 AU604249 B2 AU 604249B2 AU 76217/87 A AU76217/87 A AU 76217/87A AU 7621787 A AU7621787 A AU 7621787A AU 604249 B2 AU604249 B2 AU 604249B2
- Authority
- AU
- Australia
- Prior art keywords
- carbon atoms
- groups
- group
- chain
- straight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Polyethers (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Compounds of the general formula I <IMAGE> in which Y is a nitrogen or phosphorus atom, A<1> and A<2> are identical or different and are each a straight-chain or branched alkylene group having 2 to 6 carbon atoms, U<1>, U<2>, U<3>, U<4> are identical or different and are each a direct bond or a straight-chain or branched alkylene group having 1 to 6 carbon atoms, D<1>, D<2>, D<3>, D<4> are identical or different and are each an oxygen or sulphur atom, an alkylene group having 1 to 6 carbon atoms or a group N-R<7> where R<7> has the meaning of a hydrogen atom, a straight-chain or branched alkylene chain having 1 to 4 carbon atoms, which carries a COOR<1> group at the end, in which R<1> represents a hydrogen atom or a metal ion equivalent, D<5> has the meaning given for D<1>, D<2>, D<3> and D<4> and the group <IMAGE> where R<5> has the meaning of a hydrogen atom or of a straight-chain or branched, saturated or unsaturated C1-C20-alkylene group which may contain imino, phenyleneoxy, phenyleneimino, amide, ester groups, oxygen, sulphur and/or nitrogen atoms and may be substituted by hydroxyl, mercapto, imino and/or amino groups and has either a functional group or bound via this group a macromolecule B at the end, s and t are integers from 0 to 5, R<2> is hydrogen, a linear or branched, saturated or unsaturated, alkyl, acyl or acylalkyl group of 1 to 16 carbon atoms which is unsubstituted or substitute by one or more hydroxyl or lower alkoxy groups, or is -CH2-X-V where X has the meaning of carbonyl, of a straight-chain or branched alkylene group having 0 to 10 carbon atoms, which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or of a straight &tilde& chain or branched alkylene group having 2 to 23 carbon atoms which is interrupted by oxygen atoms, V has the meaning <IMAGE> or -COOR<6> in which R<3> and R<4>, independently of one another, are hydrogen, a linear o branched alkyl group having 1 to 16 carbon atoms which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or R<3> and R<4> together with the nitrogen atom represent a saturated 5- or 6-membered ring which may contain a further hetero atom and R<6> represents hydrogen or a saturated, unsaturated, straight-chain or branched or cyclic hydrocarbon radical having up to 16 carbon atoms or represents an aryl or aralkyl group, or R<2> or R<3> denotes a second macrocycle of the formula I' <IMAGE> which is bound via an alkylene chain (K) containing 2 to 20 carbon atoms, which, if desired carries carbonyl groups at the ends and, if desired, is interrupted by one or more oxygen atoms or R<1>-carboxymethylimino groups or substituted by one or more hydroxyl, lower alkoxy or carboxy-lower alkyl groups, which macrocycle can have a structure which is different from that of the parent structure, or R<2> denotes B or CH2-COB, with the proviso that if Rz represents B or CH2-COB, R<5> denotes a hydrogen atom, that at least two COORi groups are present in the molecule and that two hetero atoms of the macrocycle are each bound to at least two carbon atoms via an alkylene group and functional groups present in the molecule are, if desired conjugated with macromolecules and, if desired free carboxyl groups have been converted with organic or inorganic bases or amino acids and basic groups with inorganic or organic acids to the salts.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3625417A DE3625417C2 (en) | 1986-07-28 | 1986-07-28 | Tetraazacyclododecane derivatives |
| DE3625417 | 1986-07-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU7621787A AU7621787A (en) | 1988-02-04 |
| AU604249B2 true AU604249B2 (en) | 1990-12-13 |
| AU604249C AU604249C (en) | 1993-09-16 |
Family
ID=
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU620841B2 (en) * | 1987-12-24 | 1992-02-27 | Bracco International B.V. | Macrocyclic chelating agents and chelates thereof |
| AU625529B2 (en) * | 1989-12-22 | 1992-07-16 | E.R. Squibb & Sons, Inc. | 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes |
| AU634167B2 (en) * | 1988-06-24 | 1993-02-18 | Dow Chemical Company, The | Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| AU656304B2 (en) * | 1989-04-07 | 1995-02-02 | Salutar, Inc. | Chelants |
| AU658566B2 (en) * | 1986-03-21 | 1995-04-27 | Hybritech Incorporated | Improvements in or relating to methods for providing internal references for use in analyte-receptor assays |
| US10793532B2 (en) | 2016-09-27 | 2020-10-06 | Bayer Pharma Aktiengesellschaft | Method for producing the crystalline form of modification a of calcobutrol |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU658566B2 (en) * | 1986-03-21 | 1995-04-27 | Hybritech Incorporated | Improvements in or relating to methods for providing internal references for use in analyte-receptor assays |
| AU620841B2 (en) * | 1987-12-24 | 1992-02-27 | Bracco International B.V. | Macrocyclic chelating agents and chelates thereof |
| AU634167B2 (en) * | 1988-06-24 | 1993-02-18 | Dow Chemical Company, The | Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| AU656304B2 (en) * | 1989-04-07 | 1995-02-02 | Salutar, Inc. | Chelants |
| AU625529B2 (en) * | 1989-12-22 | 1992-07-16 | E.R. Squibb & Sons, Inc. | 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes |
| US10793532B2 (en) | 2016-09-27 | 2020-10-06 | Bayer Pharma Aktiengesellschaft | Method for producing the crystalline form of modification a of calcobutrol |
| US11390592B2 (en) | 2016-09-27 | 2022-07-19 | Bayer Pharma Aktiengesellschaft | Method for producing the crystalline form of modification a of calcobutrol |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0255471B1 (en) | 1992-09-09 |
| NO174048C (en) | 1994-03-09 |
| NO873132L (en) | 1988-01-29 |
| ES2052599T3 (en) | 1994-07-16 |
| DK393387D0 (en) | 1987-07-28 |
| JPS6341468A (en) | 1988-02-22 |
| NO873132D0 (en) | 1987-07-27 |
| DK393387A (en) | 1988-01-29 |
| ZA875561B (en) | 1989-03-29 |
| NZ221225A (en) | 1990-09-26 |
| AU7621787A (en) | 1988-02-04 |
| PT85410B (en) | 1990-06-29 |
| IE872038L (en) | 1988-01-28 |
| CA1341176C (en) | 2001-01-30 |
| DK171574B1 (en) | 1997-01-20 |
| DE3781620D1 (en) | 1992-10-15 |
| ATE80391T1 (en) | 1992-09-15 |
| EP0255471A1 (en) | 1988-02-03 |
| JPH0753720B2 (en) | 1995-06-07 |
| IE60677B1 (en) | 1994-08-10 |
| DE3625417A1 (en) | 1988-02-11 |
| GR3005808T3 (en) | 1993-06-07 |
| DE3625417C2 (en) | 1998-10-08 |
| NO174048B (en) | 1993-11-29 |
| PT85410A (en) | 1987-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA875561B (en) | Macrocyclic compounds | |
| GR3005807T3 (en) | ||
| KR910007704A (en) | Fibrinogen receptor antagonist | |
| MY106980A (en) | Heterocyclic compounds | |
| ATE53860T1 (en) | FUEL MIXTURE. | |
| DE59402226D1 (en) | Use of organofunctionally modified polysiloxanes for defoaming diesel fuel | |
| MX165512B (en) | CARBAMATE ADDITIVE FOR LUBRICATING COMPOSITION | |
| ES2035261T3 (en) | COMPOSITIONS OF OIL AND FUEL OIL CRUDES. | |
| EP0250358A3 (en) | Novel complex compounds | |
| EP0780372A3 (en) | 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation | |
| ES8800321A1 (en) | Additive for heated bitumen. | |
| EP0341925A3 (en) | An inorganic filler containing polyolefin composition | |
| DE69203551D1 (en) | Biodegradable copolyester of 4-hydroxyproline and pharmaceutical composition containing it. | |
| ATE66957T1 (en) | USE OF RARE EARTH MIXTURES TO STABILIZE FUELS FOR DIESEL ENGINES. | |
| KR930000491A (en) | Dicarboxylic acid derivative and its manufacturing method | |
| ATE189215T1 (en) | COMPOSITIONS, CONCENTRATES, LUBRICANT COMPOSITIONS, FUEL COMPOSITIONS, AND FUEL ECONOMY IMPROVEMENT METHOD OF INTERNAL COMBUSTION ENGINES | |
| ATE38675T1 (en) | PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT. | |
| FR2616663B1 (en) | NOVEL NITROGEN POLYCYCLIC STRUCTURE TRIPEPTIDES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| GB1489849A (en) | 4,4'-bi-piperidylidene derivatives and their use as polymer stabilizers | |
| KR860007222A (en) | Method for preparing benzo [a] phenazine derivative | |
| ES2012763B3 (en) | WELDING COMPOSITIONS. | |
| KR890010089A (en) | Curable Resin Composition | |
| ATE46158T1 (en) | 1,3-DITHIOL DERIVATIVES. | |
| AU8060487A (en) | 4-hydroxy-4-(substituted thioalkenyl)-cyclohexane- carboxylic acids and derivatives thereof |